Rocket Pharmaceuticals sells priority review voucher for $180 million

Go back to Rocket Pharmaceuticals sells priority review voucher for $180 million
(NASDAQ: RCKT) Delayed: 2.75 +0.09 (3.38%)
Previous Close $2.66    52 Week High
Open $2.66    52 Week Low
Day High $2.83    P/E N/A 
Day Low $2.66    EPS
Volume 2,441,796